Novartis and BenevolentAI sign AI oncology deal

09-09-2019

Sarah Morgan

Novartis and BenevolentAI sign AI oncology deal

II.studio / Shutterstock.com

Swiss pharmaceutical company Novartis has united with BenevolentAI to aid in the discovery and development of new treatments.


Novartis, BenevolentAI, drug discovery, machine learning, artificial intelligence, drug development, AI, technology, oncology

LSIPR